Table 2.
Peripheral Blood Mononuclear Cell Phenotyping of 2 patients with Goldenhar Syndrome
| MONONUCLEAR CELL PHENOTYPES |
% OF TOTAL GATED POPULATION |
CELL COUNTS |
||
|---|---|---|---|---|
|
PATIENT 1 |
PATIENT 2 |
PATIENT 1 |
PATIENT 2 |
|
| 3 y | 7 y | (#/mm^3) 3 y | (#/mm^3) 7 y | |
| CD45+ (Purity) |
100.0 (100) |
100.0 (100) |
2483 (N/A) |
1726 (N/A) |
| CD3-CD56,16+ |
12.5 (3.0–18.6) |
17 (5–21) |
311 (123–785) |
815 (128–474) |
| CD56+ |
10.1 (6.2–23.2) |
17 (6–23) |
251 (137–478) |
815 (137–478) |
| CD2+ |
64.6 (69.8–93.2) |
64 (70–93) |
1604 (884–2800) |
3068 (884–2800) |
| CD3+ (Total) |
57.5 (58.0–74.0) |
58 (56–76) |
1427 (1656–3841) |
2781 (991–2997) |
| CD3+CD4+ |
39.6 (28.0–47.2) |
33.9 (25–48) |
983 (871–2379) |
1625 (635–1620) |
| CD3+CD8+ |
15.5 (16.0–31.8) |
19 (16–43) |
384 (518–1433) |
911 (293–1221) |
| CD19+ |
28.7 (12.8–30.6) |
24 (11–28) |
713 (421–1397) |
1151 (249–865) |
| CD20+ |
27.7 (2.7–24.9) |
23 (3–25) |
688 (59–457) |
1103 (59–457) |
| CD19+CD27+ |
2.1 (1.0–5.2) |
1.9 (1–5) |
52 (19–131) |
91 (19–131) |
| HLA-DR+ |
36.3 (8.9–36.4) |
29 (9–36) |
901 (177–692) |
1390 (59–457) |
| CD4+CD45RA+ |
27.6 (3.3–32.9) |
24 (3–33) |
686 (134–969) |
1151 (134–969) |
| CD4+CD45RO+ |
10.8 (15.6–41.8) |
10 (16–42) |
269 (301–919) |
479 (301–919) |
| CD4/CD8 Ratio | 2.56 (0.72–2.94) | 1.78 (0.69–2.63) | N/A | N/A |
Age-related normal ranges in parenthesis are taken from Allergy and Immunology Laboratory, Texas Children’s Hospital, Houston, Texas. Controls of the day were run but not shown here.